Prevalence of class I–III BRAF mutations among 114,662 cancer patients in a large genomic database

BRAF mutations are relatively common in many cancers, particularly melanoma, colorectal cancer, and thyroid cancer and to a lesser extent in lung cancer. These mutations can be targeted by BRAF and MEK inhibitors, which exhibit good clinical activity. There are conflicting reports of the various rel...

Fuld beskrivelse

Na minha lista:

Bibliografiske detaljer
Udgivet i:	Exp Biol Med (Maywood)
Main Authors:	Owsley, Jeff, Stein, Matthew K, Porter, Jason, In, Gino K, Salem, Mohamed, O’Day, Steven, Elliott, Andrew, Poorman, Kelsey, Gibney, Geoffrey, VanderWalde, Ari
Format:	Artigo
Sprog:	Inglês
Udgivet:	SAGE Publications 2020
Fag:	Original Research
Online adgang:	https://ncbi.nlm.nih.gov/pmc/articles/PMC7797994/ https://ncbi.nlm.nih.gov/pubmed/33019809 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1535370220959657
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!

Prevalence of class I–III BRAF mutations among 114,662 cancer patients in a large genomic database

Lignende værker